For the past three decades, the University of Texas Health Science Center at San Antonio (UTHSCSA) has hosted a premier Training Program in the biology of aging that has resulted in the development of a new generation of leaders in this field. This application seeks to continue this T32 Training Program and we request funds to support four predoctoral and four postdoctoral trainees. In this funding period, we are building on our unparalleled record of success and expand the program to prepare trainees in the emerging area of Geroscience, term that encompasses (1) fundamentals of basic aging biology; (2) the relationship between aging biology and the etiology of age-related disease; and (3) principles of translational research in biological aging. Our overarching objective is to catalyze development of interventions that modulate the aging process, leading to an extension of healthspan. The achievement of this goal requires a cadre of dedicated young researchers who have received multi-disciplinary training. Thus, this T32 Training Program aims to attract outstanding young scientists and train them in a vibrant and collaborative environment rich in Geroscience resources. The Training Program involves 48 faculty members and takes advantage of the synergies created by their intense collaborations across 7 departments. Our Geroscience training environment is second to none, and features the Barshop Institute, a Nathan Shock Center, our new Claude D. Pepper Center, a Geriatric Research, Education and Clinical Center, and the Interventions Testing Program. Since 1988, this T32 has trained many outstanding researchers in Geroscience, including current members of the current T32 Faculty. Our former trainees have been awarded numerous federal grants (including F, K and R series awards), and include Assistant or Associate Professors. Drs. Nicolas Musi, Peter Hornsby and Veronica Galvan will co-direct this Program and are supported by an Internal Steering Committee and an External Advisory Committee. The Faculty expertise crosses the spectrum of aging biology (inflammation, senescence, metabolism, epigenetics, macromolecular damage, proteostasis, stem cells); genesis of age-related diseases (cancer, diabetes, Alzheimer's disease, osteoporosis, sarcopenia); and early-phase translational research. The principal components of the Training Program are: (1) participation with graded responsibility in the laboratory of an experienced investigator; (2) commitment to collaboration and the use of multidisciplinary research approaches; (3) continuing research-in-progress seminars; (4) integrated lecture/journal club series on Geroscience; (5) courses and seminars in the responsible conduct of research, scientific communication, grantsmanship and peer review; (6) a rigorous group mentoring design; (7) preparation of an individual development plan and comprehensive evaluation of trainee progress; (8) continued evaluation and teaching of mentoring skills for faculty preceptors; and (9) active recruitment of meritorious trainees and faculty preceptors to reflect workforce ethnic/racial diversity. Trainee access to on-going departmental conferences, clinical rounds and courses further enhances the training experience.

Public Health Relevance

- PUBLIC RELEVANCE The number of senior citizens is expected to almost double and to comprise more than 20 percent of the U.S. population by the year 2050. Therefore, there is an urgent need to accelerate the development of strategies that will improve the health of our citizens as they age. The achievement of this goal requires the formation of a strong body of motivated young researchers with outstanding training in aging research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Institutional National Research Service Award (T32)
Project #
5T32AG021890-17
Application #
9913310
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Guo, Max
Project Start
2003-05-01
Project End
2024-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Lewis, Kaitlyn N; Rubinstein, Nimrod D; Buffenstein, Rochelle (2018) A window into extreme longevity; the circulating metabolomic signature of the naked mole-rat, a mammal that shows negligible senescence. Geroscience 40:105-121
Garbarino, Valentina R; Gilman, T Lee; Daws, Lynette C et al. (2018) Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res :
Jahrling, Jordan B; Lin, Ai-Ling; DeRosa, Nicholas et al. (2018) mTOR drives cerebral blood flow and memory deficits in LDLR-/- mice modeling atherosclerosis and vascular cognitive impairment. J Cereb Blood Flow Metab 38:58-74
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Zhang, Shen-Ying; Clark, Nathaniel E; Freije, Catherine A et al. (2018) Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection. Cell 172:952-965.e18
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Deng, Yilun; Qin, Yuejuan; Srikantan, Subramanya et al. (2018) The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex. Hum Mol Genet 27:1794-1808
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Deepa, Sathyaseelan S; Pharaoh, Gavin; Kinter, Michael et al. (2018) Lifelong reduction in complex IV induces tissue-specific metabolic effects but does not reduce lifespan or healthspan in mice. Aging Cell :e12769
Lin, Ai-Ling; Jahrling, Jordan B; Zhang, Wei et al. (2017) Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer's disease. J Cereb Blood Flow Metab 37:217-226

Showing the most recent 10 out of 124 publications